New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2014
12:38 EDTUSNA, GOOG, DDD, MYGN, MRK, BIRT, CVS, SSYSOn The Fly: Midday Wrap
Stocks on Wall Street were mixed at midday after ADP reported that dismal weather in January put a damper on private sector hiring. The market seemed indecisive in the opening 30 minutes of trading, but soon picked up downside momentum. The Nasdaq, which was down more than 1% early in the session, has trimmed its losses and the Dow has moved into positive ground, though just barely. ECONOMIC EVENTS: In the U.S., payroll company ADP reported that 175,000 service jobs were created in January, versus the expectations for 185,000 net new positions to have been added. The ISM services index rose to 54.0 in January from December's 53.0 reading, which was a bit ahead of expectations. COMPANY NEWS: Dow component Merck (MRK) advanced fractionally after the drug company’s quarterly results were generally in-line with expectations and it also announced three clinical collaboration agreements to evaluate its investigational anti-PD-1 immunotherapy… Shares of Google (GOOG) are advancing in a down market after the search giant reached a settlement with European Union regulators over antitrust allegations and research firm Bernstein hiked its price target on the stock to $1,500 from $1,350... CVS Caremark (CVS) announced plans to cease selling all tobacco products, including cigarettes, at all its locations starting October 1. MAJOR MOVERS: Among the notable gainers was multi-level-marketer USANA Health Sciences (USNA), which rose 17% after its results and guidance beat expectations. Also higher were shares of molecular diagnostic company Myriad Genetics (MYGN), which climbed over 11% after the company reported second quarter results that beat consensus expectations, raised its fiscal 2014 outlook, and announced the acquisition of Crescendo Bioscience. Among the noteworthy losers was 3D Systems (DDD), which plunged 16% after the maker of 3D printers and supplies lowered its profit outlook for the current fiscal year and guided to earnings next year below the consensus estimate. A number of 3D Systems’ peers fell as well, with the next biggest company in the sector, Stratasys (SSYS), also declining 3%. Also lower were shares of Actuate (BIRT), which slid about 17% after reporting earnings, announcing the acquisition of German software developer legodo ag and being downgraded at Drexel Hamilton. INDICES: Near midday, the Dow was up 13.12, or 0.08%, to 15,458.36; the Nasdaq was down 13.59, or 0.34%, to 4,017.93; and the S&P 500 was down 2.14, or 0.12%, to 1,753.06.
News For DDD;SSYS;MRK;GOOG;CVS;MYGN;USNA;BIRT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
November 12, 2014
06:12 EDTGOOGVestager says not all concerns about Google can be covered by inquiry, WSJ says
New EU antitrust chief Margrethe Vestager says she will investigate the concerns posed by Google’s control over large amounts of data, but notes that not all of society’s concerns can be addressed by the competition case, the Wall Street Journal reports. Reference Link
November 11, 2014
16:01 EDTMRKOptions Update; November 11, 2014
Subscribe for More Information
15:59 EDTGOOGYouTube strikes music deals, paving way for streaming service, FT says
Subscribe for More Information
15:43 EDTMRKLeerink major pharma & biotech analysts hold analyst/industry conference call
Subscribe for More Information
13:55 EDTGOOGYuoTube hires Zynga executive to lead consumer products group, Re/code says
Google's (GOOG) YouTube has hired Manuel Bronstein, a Zynga (ZNGA) executive, to lead its consumer products group, says Re/code. According to the Re/code report, YouTube has had a series of notable managers depart in the last year. Reference Link
13:38 EDTGOOGNew European antitrust chief needs time to resolve Google probe, Reuters says
Subscribe for More Information
13:36 EDTGOOGGoogle launches Google Fiber for small businesses
Google announced that it had launched a high speed Internet service, Google Fiber, for small businesses in select areas of Kansas City. Google will charge $100 per month for the service.
09:37 EDTMRKActive equity options trading
Subscribe for More Information
08:10 EDTMRKMerck reports results from Phase 2 study of Grazoprevir/Elbasvir
Subscribe for More Information
November 10, 2014
12:45 EDTGOOGFullscreen to acquire Rooster Teeth, terms not disclosed, Reuters reports
Subscribe for More Information
10:04 EDTMYGNOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:20 EDTMRK, DDDOn The Fly: Pre-market Movers
Subscribe for More Information
08:48 EDTMRKGilead rises after Merck presents data on HCV combo
Subscribe for More Information
08:09 EDTDDD3D Systems backs FY14 EPS view 70c-80c
Subscribe for More Information
08:07 EDTDDD3D Systems reports Q3 EPS 18c, consensus 17c
Subscribe for More Information
07:20 EDTMRKGilead overhang from Merck HCV combo removed, says Wells Fargo
Subscribe for More Information
07:11 EDTGOOGOpen Mobile Media to hold a summit
Subscribe for More Information
06:18 EDTMYGNMyriad Genetics initiated with an Underweight at Morgan Stanley
Subscribe for More Information
06:04 EDTGOOGGoogle's same-day delivery head leaves for Uber, Re/code reports
The head of Google Express' same-day delivery service, Tom Fallows, has left the company to join Uber, Re/code reported on Friday, citing sources. Reference Link
November 9, 2014
18:58 EDTMRKMerck presents interim data from C-SWIFT study
Merck announced the presentation of interim data from the C-SWIFT study exploring the potential of a candidate triple-therapy regimen consisting of the fixed-dose combination of grazoprevir/elbasvir , the company’s investigational NS3/4A protease inhibitor and NS5A inhibitor, in combination with sofosbuvir, a nucleotide inhibitor for the treatment of chronic hepatitis C virus, HCV, infection. Preliminary findings in treatment-naïve HCV genotype 1- infected non-cirrhotic patients, following six and four weeks of treatment, and patients with cirrhotic disease, following eight and six weeks of treatment, will be presented by Dr. Eric Lawitz, vice president, scientific and research development, The Texas Liver Institute, San Antonio, TX and C-SWIFT lead investigator. This poster presentation is part of a late-breaking abstract session at the 65th American Association for the Study of Liver Diseases, AASLD, Annual Meeting, also known as The Liver Meeting. “These interim data provide a compelling proof-of-concept for the potential of an eight- or six-week triple therapy course in treatment-naive patients with genotype 1 disease, including cirrhotic patients,” said Dr. Lawitz. “These findings will inform the design of larger studies aimed at understanding the potential of short-duration triple therapy across multiple patient types.”
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use